Once tumor had reached a volume of 50 mm3, three intratumoral (i.t.)administrations of in total 3 × 106 TCID50 (MV-CD30 or VSV-CD30) or 3 × 108 TCID50 (VSV-CD30) were performed within one week. Here, TNFRSF8 is linked to neoplasm.